Thiazole-Bearing 4-Thiazolidinones as New Anticonvulsant Agents
Here, we describe the synthesis and anticonvulsant activity of thiazole-bearing hybrids based on 2-imino-4-thiazolidinone and 2,4-dioxothiazolidine-5-carboxylic acid cores. The structure of target compounds was based on the following: (i) A combination of two thiazole cores; (ii) similarity to ralitolin’s structure; (iii) the compliance with structural requirements for the new anticonvulsants. Target compounds were synthesized via known approaches based on Knoenavegel reaction, alkylation reaction, and one-pot three-component reaction. Anticonvulsant properties of compounds were evaluated in two different models—pentylenetetrazole-induced seizures and maximal electroshock seizure tests. Among the tested compounds 5Z-(3-nitrobenzylidene)-2-(thiazol-2-ylimino)-thiazolidin-4-one Ib, 2-[2,4-dioxo-5-(thiazol-2- ylcarbamoylmethyl)-thiazolidin-3-yl]-N-(2-trifluoromethylphenyl)acetamide IId and (2,4-dioxo-5- (thiazol-2-ylcarbamoylmethylene)-thiazolidin-3-yl)acetic acid ethyl ester IIj showed excellent anticonvulsant activity in both models. The directions of compounds modification based on SAR aspects were discussed. The results of the study provide a basis for further study of the anticonvulsant properties of selected thiazole-thiazolidinones.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Journal of Molecular Structure
6 publications, 8.11%
|
|
|
Molecules
5 publications, 6.76%
|
|
|
ChemistrySelect
4 publications, 5.41%
|
|
|
Phosphorus, Sulfur and Silicon and the Related Elements
3 publications, 4.05%
|
|
|
Polycyclic Aromatic Compounds
3 publications, 4.05%
|
|
|
Scientia Pharmaceutica
2 publications, 2.7%
|
|
|
Pharmaceuticals
2 publications, 2.7%
|
|
|
Journal of the Iranian Chemical Society
2 publications, 2.7%
|
|
|
Russian Journal of General Chemistry
2 publications, 2.7%
|
|
|
Chemistry and Biodiversity
2 publications, 2.7%
|
|
|
Russian Journal of Organic Chemistry
2 publications, 2.7%
|
|
|
Journal of Sulfur Chemistry
2 publications, 2.7%
|
|
|
Archiv der Pharmazie
2 publications, 2.7%
|
|
|
Current Nanoscience
1 publication, 1.35%
|
|
|
Current Physical Chemistry
1 publication, 1.35%
|
|
|
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 1.35%
|
|
|
Acta crystallographica. Section C, Structural chemistry
1 publication, 1.35%
|
|
|
ChemMedChem
1 publication, 1.35%
|
|
|
Medicinal Chemistry Research
1 publication, 1.35%
|
|
|
Bioorganic Chemistry
1 publication, 1.35%
|
|
|
Epilepsy Research
1 publication, 1.35%
|
|
|
Chemical Data Collections
1 publication, 1.35%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.35%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 1.35%
|
|
|
Journal of Organic Chemistry
1 publication, 1.35%
|
|
|
Current Drug Targets
1 publication, 1.35%
|
|
|
RSC Medicinal Chemistry
1 publication, 1.35%
|
|
|
Chemical Biology and Drug Design
1 publication, 1.35%
|
|
|
Chemical Record
1 publication, 1.35%
|
|
|
Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials
1 publication, 1.35%
|
|
|
1
2
3
4
5
6
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
Wiley
13 publications, 17.57%
|
|
|
Elsevier
12 publications, 16.22%
|
|
|
MDPI
11 publications, 14.86%
|
|
|
Taylor & Francis
10 publications, 13.51%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 8.11%
|
|
|
Springer Nature
6 publications, 8.11%
|
|
|
Pleiades Publishing
5 publications, 6.76%
|
|
|
American Chemical Society (ACS)
4 publications, 5.41%
|
|
|
International Union of Crystallography (IUCr)
2 publications, 2.7%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 2.7%
|
|
|
A and V Publications
2 publications, 2.7%
|
|
|
Georg Thieme Verlag KG
1 publication, 1.35%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.